About FDA
Percentage of inquiries resolved via IAS Action within 10 business days of date assigned during the month
Dictionary: Globalization changed FDA’s environment for regulating products. Based on the volume of imported products, FDA identified China, India, the Middle East, Europe, and Latin America as areas in which to establish a permanent presence. These foreign posts send inquiries/requests for information to FDA headquarters. The International Affairs Staff in the Office of the Center Director is responsible for responding and/or coordinating responses with technical experts to inquiries from foreign posts concerning food and cosmetic products. This measure evaluates CFSAN's timeliness in responding to these inquiries.
Fiscal Year - 2011
| Time | Target | Percentage |
|---|---|---|
| Oct 2010 | 85 | 96 |
| Nov 2010 | 85 | 100 |
| Dec 2010 | 85 | 95 |
| Jan 2011 | 85 | 100 |
| Feb 2011 | 85 | 100 |
| Mar 2011 | 85 | 100 |
| Apr 2011 | 85 | 88 |
| May 2011 | 85 | 91 |
| Jun 2011 | 85 | 88 |
| Jul 2011 | 85 | 92 |
| Aug 2011 | 85 | 97 |
| Sep 2011 | 85 | 98 |
FY 2011 Overall: 96%
Number of inquiries resolved via IAS Action within 10 business days of date assigned during the month
Fiscal Year - 2011
| Time | Target | Number |
|---|---|---|
| Oct 2010 | N/A | 24 |
| Nov 2010 | N/A | 20 |
| Dec 2010 | N/A | 42 |
| Jan 2011 | N/A | 21 |
| Feb 2011 | N/A | 13 |
| Mar 2011 | N/A | 22 |
| Apr 2011 | N/A | 21 |
| May 2011 | N/A | 21 |
| Jun 2011 | N/A | 7 |
| Jul 2011 | N/A | 35 |
| Aug 2011 | N/A | 28 |
| Sep 2011 | N/A | 47 |
FY 2011 Total: 301
Total number of inquiries received via IAS Action during the month
Fiscal Year - 2011
| Time | Target | Number |
|---|---|---|
| Oct 2010 | N/A | 25 |
| Nov 2010 | N/A | 20 |
| Dec 2010 | N/A | 44 |
| Jan 2011 | N/A | 21 |
| Feb 2011 | N/A | 13 |
| Mar 2011 | N/A | 22 |
| Apr 2011 | N/A | 24 |
| May 2011 | N/A | 23 |
| Jun 2011 | N/A | 8 |
| Jul 2011 | N/A | 38 |
| Aug 2011 | N/A | 29 |
| Sep 2011 | N/A | 48 |
FY 2011 Total: 315
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.
